Pneumococcal conjugate second or third-dose vaccines (PCVc) in Samoa
Samoa: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 89.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Samoa, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Samoa recorded 89.0% for pneumococcal conjugate second or third-dose vaccines (pcvc) in 2025.
Compared with earlier readings it is up 18.7% on the previous year.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Samoa peaked at 93.0% in 2023 and was at its lowest, 0.0%, in 2008.
That places Samoa 72nd out of 194 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Samoa, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 0.0% | — |
| 2016 | 0.0% | — |
| 2017 | 0.0% | — |
| 2018 | 0.0% | — |
| 2019 | 0.0% | — |
| 2020 | 0.0% | — |
| 2021 | 3.0% | — |
| 2022 | 36.0% | +1100.0% |
| 2023 | 93.0% | +158.3% |
| 2024 | 75.0% | -19.4% |
| 2025 | 89.0% | +18.7% |
Samoa compared with similar countries
- Samoa's 89.0% is above the median for upper middle income countries, which is 76.0%, 1.2× the median. (57 countries reporting)
- Samoa's 89.0% is above the median for East Asia & Pacific, which is 81.0%, 1.1× the median. (30 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 0.0% | 0.0% | 0.0% | 10 |
| 2020s | 49.3% | 0.0% | 93.0% | 6 |
Countries ranked near Samoa
More health data for Samoa
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.71 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 708.7 deaths per 1,000 people (2090)
- Number of infants who die before age 1 17 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 1 (2025)
- Population ages 00-04, female, annual growth rate -2.45 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0591 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.5 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Samoa?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Samoa was 89.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Samoa?
- The highest recorded value was 93.0% in 2023.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Samoa?
- The lowest recorded value was 0.0% in 2008.
- How does Samoa rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Samoa ranks 72nd out of 194 countries with data for 2025.
- Where does this Samoa data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).